We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Falanx Group Limited | LSE:FLX | London | Ordinary Share | VGG3338A1075 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.525 | 0.50 | 0.55 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
10/10/2022 18:35 | The business is building momentum nicely but it's not being reflected in the share price.The Interim statement for the 6 months to September due fairly soon will hopefully kick start the upward trend. From the last update: Our focus is now on growing market share, and we are achieving this through indirect and direct routes. Since Falanx became a pure play cyber business in October 2021, we have invested in an expanded sales and marketing capability, and this is now starting to deliver results. We have new partners on board and they are already generating sales from a strong pipeline of potential business. Our penetration testing business remains strong, and we have a growing customer base of around 400 organisations, which provides us with a good basis for cross selling of MRR generating services. With the conversion of this pipeline, which is now underway, and the planned cessation of certain spends incurred in the first half of FY23, we expect an improving financial performance in the second half of FY23. Falanx is now firmly in growth mode, and our objective, which we are confident we will achieve, is to generate very significant, organic growth over the coming months and year s. We are well financed and expect our existing financial resources to be sufficient to see us through to profitability . | z1co | |
05/10/2022 08:32 | Number 1 , there is no lack of cash circa around £2.5millionNumber 2, if they are in Las Vegas that's great they are networking and expanding market in North AmericaNumber 3, what are your sources so I can verify? | wololol | |
04/10/2022 14:27 | Trading update due any time this month for the first 6 months performance. Should be juicy. Hopefully some more Directors purchases too. | wololol | |
04/10/2022 09:04 | How about quoting the source of your cut and paste quotes. Otherwise, they will just be regarded as fake news ! | joe kingl | |
04/10/2022 06:33 | The global MDR market size is expected to grow from an estimated value of USD 2.6 billion in 2022 to USD 5.6 billion by 2027, at a Compound Annual Growth Rate (CAGR) of 16.0% from 2022 to 2027Some of the factors that are driving the market growth includes addressing of shortage of skilled cybersecurity professionals and budget constraints, government regulations, and strict compliance for adoption of MDR services across the segments. | wololol | |
01/10/2022 06:41 | MarketsandMarkets forecasts the global Penetration Testing market size is expected to grow from an estimated value of USD 1.4 billion in 2022 to 2.7 billion USD by 2027, at a Compound Annual Growth Rate (CAGR) of 13.7% from 2022 to 2027. Some of the factors that are driving the market growth include the presence of stringent regulations and compliances mandating regular penetration testing practices, increasing sophistication of cyberattacks resulting in financial and reputational losses for organizations, and increased internet penetration and use of smartphones resulting in a surge in mobile-based business-critical applications.What other markets are expected to grow in the global economy? Definitely in the right place here. | wololol | |
30/9/2022 20:46 | The clue is the time, anything Amati sells tends to be a worked sale so it shows after the close, in this case 4.38pm. Think I have 1.5 million spread around a few accounts. I have held more in the past but I had a reduction everywhere when the markets turned sour. I'm not selling this low and I'm not buying more, unless I see some huge volumes or the Amati stake get crossed with a new buyer | dave4545 | |
30/9/2022 20:43 | How do you know it was Amati? The highest sell price was 0.58 so I doubt they would get 0.6 for 1 million shares. Looks more like a buy to me but please enlighten me. How many shares you holding Dave? I'm approaching 2 mill and will keep buying every month till about 4 mill at these prices. Got another trench ready for next week. | wololol | |
30/9/2022 18:38 | 1 mil from Amati today It's a low grind 44.3 million left to go | dave4545 | |
30/9/2022 12:04 | Yes and not many sells just a random pi sells. Maybe Amati have got down to were they want or hold at after the results? If buys start going through at 0.65 I think we will see an influx of buying and more volume | wololol | |
30/9/2022 09:38 | Pleasantly surprised at the decent buys going through atm. | dave4545 | |
29/9/2022 15:25 | Yep but if that and the million are director buys it's a start. | dave4545 | |
29/9/2022 14:58 | £7500 - huge? - I think not | toffeeman | |
29/9/2022 13:30 | Huge buy gone throught 1.325 million | wololol | |
29/9/2022 11:38 | Give them time Dave, results only released 4 hours ago. I expect they will be buying in the next few weeks. | wololol | |
29/9/2022 10:20 | No signs of them buying yet If they are this bullish they should be buying millions that are available under 0.6p | dave4545 | |
29/9/2022 10:18 | The company is very bullish for year ending 2023 and 2024. From today's rns: Post Period update The NNN team is now established and consequently the overall cyber sales pipeline is now building on a weekly basis, and it is already at a record value of GBP6.0m (GBP4.1m on 1 April 2022). This also represents growth of 46% in the current financial year, and very significantly the pipeline is now 66% MRR compared to 40% in April 2022 (and 17% in April 2021). Our team has a high energy level and a strong execution focus and as well as building new partnerships, our existing relationships have been revitalised and expanded. Sales orders for our core services in the first five months of FY23 were 18% ahead of the same period in FY22. This includes five new MDR deals which we sold, with a total minimum contract value of over GBP0.2m, with the potential for significant expansion and extension beyond this. Three of these MDR deals were signed in August 2022 when we also signed up two new Tier 1 partners. Furthermore, we have also won our first four clients for CVS and also sold more than 1000 f:CEL licenses. | z1co | |
29/9/2022 09:45 | Yes, I would expect to see the directors take some shares at such a low price now they are not in a closed period | sclper | |
29/9/2022 08:05 | Yes I was thinking the same Dave. I just keep buying knowing that I getting a gift at 50% discount to what the Directors paid only a few months ago. It's basically stealing at these prices honestly | wololol | |
29/9/2022 07:53 | There's a point the directors should be piling in, they were all over this at double the price so now they are out of their closed period here is their chance to add | dave4545 | |
29/9/2022 07:48 | Dave I totally agree. As a long term holder though I am delighted with the results especially now knowing they don't have to raise cash and the revenues in 2023 should be significantly higher. Valued at 3million I'm happy to keep adding at these levels until the wider market improves. The absolute bottom is 0.5 and that's already been tested several times and always bounced. So the risk/reward is very in favour of reward to 1p minimum in my views. My stake is approaching that now of the Directors. | wololol |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions